Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
A

ACRV

Nasdaq

Acrivon Therapeutics, Inc.

Latest disclosureOctober 7, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 10 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 43

Limited filing history
All43Buying0Selling10Other33
Filters

Last 30 daysNo qualifying insider buying. Sales: $585.06 by 1 insider.

43 trades · April 17, 2026 – October 5, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Sale disclosed

Mary Miller

Chief Legal Officer

Common Stock

Reported value
$585.06
Reported price
$1.99 / share
Traded October 5, 2026Filed October 7, 2026SEC filing
Award disclosed

Michaela Levin

Chief Business Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 31, 2026Filed September 2, 2026SEC filing
Award disclosed

Michaela Levin

Chief Business Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 31, 2026Filed September 2, 2026SEC filing
Sale disclosed

Peter Blume-Jensen +1 more

President and CEO; EVP - Business Operations

Common Stock

Reported value
$30.97K
Reported price
$2.2064 / share
Traded August 25, 2026Filed August 27, 2026SEC filing
Sale disclosed

Katharine Peterson

Chief Accounting Officer

Common Stock

Reported value
$203.01
Reported price
$2.01 / share
Traded August 18, 2026Filed August 20, 2026SEC filing
Sale disclosed

Mary Miller

Chief Legal Officer

Common Stock

Reported value
$371.85
Reported price
$2.01 / share
Traded August 18, 2026Filed August 20, 2026SEC filing
Sale disclosed

Erick Gamelin

Chief Development Officer

Common Stock

Reported value
$804
Reported price
$2.01 / share
Traded August 18, 2026Filed August 20, 2026SEC filing
Sale disclosed

Eric Devroe

Chief Operating Officer

Common Stock

Reported value
$1.21K
Reported price
$2.01 / share
Traded August 18, 2026Filed August 20, 2026SEC filing
Sale disclosed

Peter Blume-Jensen +1 more

President and CEO; EVP - Business Operations

Common Stock

Reported value
$2.47K
Reported price
$2.01 / share
Traded August 18, 2026Filed August 20, 2026SEC filing
Sale disclosed

Peter Blume-Jensen +1 more

President and CEO; EVP - Business Operations

Common Stock

Reported value
$972.84
Reported price
$2.01 / share
Traded August 18, 2026Filed August 20, 2026SEC filing
Sale disclosed

Adam D. Levy

Chief Financial Officer

Common Stock

Reported value
$1.79K
Reported price
$1.57 / share
Traded August 4, 2026Filed August 6, 2026SEC filing
Sale disclosed

Mary Miller

Chief Legal Officer

Common Stock

Reported value
$1.01K
Reported price
$1.76 / share
Traded July 21, 2026Filed July 23, 2026SEC filing
Award disclosed

Ra Capital Management +4 more

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 17, 2026Filed June 22, 2026SEC filing
Award disclosed

Michael John Tomsicek

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 17, 2026Filed June 22, 2026SEC filing
Award disclosed

Sharon Shacham

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 17, 2026Filed June 22, 2026SEC filing
Award disclosed

Santhosh Palani

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 17, 2026Filed June 22, 2026SEC filing
Award disclosed

Ivana Magovcevic-Liebisch

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 17, 2026Filed June 22, 2026SEC filing
Award disclosed

Derek DiRocco

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 17, 2026Filed June 22, 2026SEC filing
Award disclosed

Charles M. Baum

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 17, 2026Filed June 22, 2026SEC filing
Tax or exercise withholding

Peter Blume-Jensen +1 more

President and CEO; EVP - Business Operations

Common Stock

Value context
$24.57K
Reported price
$1.79 / share
Traded May 21, 2026Filed May 26, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Legal OfficerCommon StockSale294$1.99 / share$585.06Oct 5Filed Oct 7 · 2d laterSEC filing
Chief Business OfficerCommon StockGrant or award30,000Award · no purchase priceNon-cash awardAug 31Filed Sep 2 · 2d laterSEC filing
Chief Business OfficerStock Option (Right to Buy)Grant or awardDerivative units130,000Award · no purchase priceNon-cash awardAug 31Filed Sep 2 · 2d laterSEC filing
+1President and CEO; EVP - Business OperationsCommon StockSale14,036$2.21 / share$30.97KAug 25Filed Aug 27 · 2d laterSEC filing
Chief Accounting OfficerCommon StockSale101$2.01 / share$203.01Aug 18Filed Aug 20 · 2d laterSEC filing
Chief Legal OfficerCommon StockSale185$2.01 / share$371.85Aug 18Filed Aug 20 · 2d laterSEC filing
Chief Development OfficerCommon StockSale400$2.01 / share$804Aug 18Filed Aug 20 · 2d laterSEC filing
Chief Operating OfficerCommon StockSale604$2.01 / share$1.21KAug 18Filed Aug 20 · 2d laterSEC filing
+1President and CEO; EVP - Business OperationsCommon StockSale2 trades1,713avg $2.01 / share$3.44KAug 18Filed Aug 20 · 2d later
2 filings
  • 1,229 @ $2.01 · $2.47KSEC filing
  • 484 @ $2.01 · $972.84SEC filing
Chief Financial OfficerCommon StockSale1,142$1.57 / share$1.79KAug 4Filed Aug 6 · 2d laterSEC filing
Chief Legal OfficerCommon StockSale573$1.76 / share$1.01KJul 21Filed Jul 23 · 2d laterSEC filing
+4DirectorStock Option (Right to Buy)Grant or awardDerivative units20,275Award · no purchase priceNon-cash awardJun 17Filed Jun 22 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units20,275Award · no purchase priceNon-cash awardJun 17Filed Jun 22 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units20,275Award · no purchase priceNon-cash awardJun 17Filed Jun 22 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units20,275Award · no purchase priceNon-cash awardJun 17Filed Jun 22 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units20,275Award · no purchase priceNon-cash awardJun 17Filed Jun 22 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units20,275Award · no purchase priceNon-cash awardJun 17Filed Jun 22 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units20,275Award · no purchase priceNon-cash awardJun 17Filed Jun 22 · 5d laterSEC filing
+1President and CEO; EVP - Business OperationsCommon StockExercise-price or tax withholding13,729$1.79 / share$24.57KMay 21Filed May 26 · 5d laterSEC filing

Showing the latest 20 of 43 trades. Show all 43 trades

Congress transactions 0

All Congress filings
No disclosed congressional trades for ACRV in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001781174
Latest public acceptance
Oct 7, 2026, 09:02 PM UTC
Score calculated
Oct 7, 2026, 09:08 PM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.